Corporate Banner
Satellite Banner
Technology Networks Header
Tuesday, October 21, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
New Monoclonal Antibodies to Mumps Virus
Friday, April 18, 2014
3 New monoclonal antibodies function in ELISA and IFA.

Molecular Devices to Attend Fourth Annual European Lab Automation (ELA) 2014
Wednesday, April 16, 2014
Molecular Devices® will be showcasing the next generation SpectraMax® MiniMax™ 300 imaging cytometer.

Hevylite® FDA Cleared to Help Monitor Patients with IgG and IgA Myeloma
Friday, April 11, 2014
Hevylite® measures the concentration of each immunoglobulin subtype.

Immunovaccine's DepoVax™ Technology Underpins New Experimental Therapy for Cancers
Wednesday, April 09, 2014
IMV vaccine adjuvant technology of choice for Dana-Farber's HPV-related cancer clinical trial.

AB SCIEX Announces Immunosuppressants Kit for Use by Doctors in Europe to Help Care for Organ Transplant Patients
Friday, April 04, 2014
The SCIEX IVD-MS™ Immunosuppressants kit is designed to give clinicians fast, accurate information about the level of immunosuppressant drug circulating in a patient’s body.

EMD Millipore Launches New Kits for Use on Gyros’ Immunoassay Platform
Wednesday, March 26, 2014
Ready-to-use kits are fully qualified for reliable use in clinical research.

Merck Millipore Launches New Immunoassay Kits
Tuesday, March 25, 2014
Ready-to-use kits are fully qualified for reliable use in clinical research.

ChromaTrap Receives Positive Commentary in Cited Research
Thursday, March 20, 2014
Researchers cite how using the fast, sensitive ChIP technology has benefited their research.

QIAGEN Launches QuantiFERON-TB Gold In-Tube in China
Thursday, March 20, 2014
Pioneering blood test that accurately identifies people infected with Mycobacterium tuberculosis, the bacterium that causes tuberculosis.

<< 1 2 3 4 5 6 7 >>
Showing Results 31 - 40 of 358
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv